|
1
|
Xiao AY, Tan ML, Wu LM, Asrani VM, Windsor
JA, Yadav D and Petrov MS: Global incidence and mortality of
pancreatic diseases: A systematic review, meta-analysis and
meta-regression of population-based cohort studies. Lancet
Gastroenterol Hepatol. 1:45–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parker SL, Tong T, Bolden S and Wingo PA:
Cancer statistics, 1997. CA Cancer J Clin. 47:5–27. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singh D, Upadhyay G, Srivastava RK and
Shankar S: Recent advances in pancreatic cancer: Biology, treatment
and prevention. Biochim Biophys Acta. 1856:13–27. 2015.PubMed/NCBI
|
|
4
|
Frantz VK: Atlas of tumor pathology,
Section VII, Fascicles 27 and 28. Tumors of the Pancreas.
Washington, D.C.: Armed forces institute of pathology. Brit J Surg.
47:334. 1959.
|
|
5
|
Levine B and Klionsky DJ: Development by
self-digestion: Molecular mechanisms and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang CW and Klionsky DJ: The molecular
mechanism of autophagy. Mol Med. 9:65–76. 2003.PubMed/NCBI
|
|
8
|
Shintani T and Klionsky DJ: Autophagy in
health and disease: A double-edged sword. Science. 306:990–995.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:pp. 15077–15082. 2003, View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miracco C, Cosci E, Oliveri G, Luzi P,
Pacenti L, Monciatti I, Mannucci S, De Nisi MC, Toscano M,
Malagnino V, et al: Protein and mRNA expression of autophagy gene
Beclin 1 in human brain tumours. Int J Oncol. 30:429–436.
2007.PubMed/NCBI
|
|
12
|
Qiu DM, Wang GL, Chen L, Xu YY, He S, Cao
XL, Qin J, Zhou JM and Zhang YXEQ: The expression of beclin-1, an
autophagic gene, in hepatocellular carcinoma associated with
clinical pathological and prognostic significance. BMC Cancer.
14:3272014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Lu Y, Lu C and Zhang L: Beclin-1
expression is a predictor of clinical outcome in patients with
esophageal squamous cell carcinoma and correlated to
hypoxia-inducible factor (HIF)-1alpha expression. Pathol Oncol Res.
15:487–493. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou W, Yue C, Deng J, Hu R, Xu J, Feng L,
Lan Q, Zhang W, Ji D, Wu J, et al: Autophagic protein beclin 1
serves as an independent positive prognostic biomarker for
non-small cell lung cancer. PLoS One. 8:e803382013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baspinar S, Bircan S, Yavuz G and
Kapucuoglu N: Beclin 1 and bcl-2 expressions in bladder urothelial
tumors and their association with clinicopathological parameters.
Pathol Res Pract. 209:418–423. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong M, Wan XB, Yuan ZY, Wei L, Fan XJ,
Wang TT, Lv YC, Li X, Chen ZH, Chen J, et al: Low expression of
beclin 1 and elevated expression of HIF-1α refine distant
metastasis risk and predict poor prognosis of ER-positive,
HER2-negative breast cancer. Med Oncol. 30:3552013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai M, Hu Z, Liu J, Gao J, Liu C, Liu D,
Tan M, Zhang D and Lin B: Beclin 1 expression in ovarian tissues
and its effects on ovarian cancer prognosis. Int J Mol Sci.
15:5292–5303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han Y, Xue XF, Shen HG, Guo XB, Wang X,
Yuan B, Guo XP, Kuang YT, Zhi QM and Zhao H: Prognostic
significance of beclin-1 expression in colorectal cancer: A
meta-analysis. Asian Pac J Cancer Prev. 15:4583–4587. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen YB, Hou JH, Feng XY, Chen S, Zhou ZW,
Zhang XS and Cai MY: Decreased expression of beclin 1 correlates
with a metastatic phenotypic feature and adverse prognosis of
gastric carcinomas. J Surg Oncol. 105:542–547. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Korsmeyer SJ: Bcl-2 initiates a new
category of oncogenes: Regulators of cell death. Blood. 80:879–886.
1992.PubMed/NCBI
|
|
21
|
Seto M, Jaeger U, Hockett RD, Graninger W,
Bennett S, Goldman P and Korsmeyer SJ: Alternative promoters and
exons, somatic mutation and deregulation of the Bcl-2-Ig fusion
gene in lymphoma. EMBO J. 7:123–131. 1988.PubMed/NCBI
|
|
22
|
Reed JC, Miyashita T, Krajewski S,
Takayama S, Aime-Sempe C, Kitada S, Sato T, Wang HG, Harigai M,
Hanada M, et al: Bcl-2 family proteins and the regulation of
programmed cell death in leukemia and lymphoma. Cancer Treat Res.
84:31–72. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Naccarato AG, Viacava P, Vignati S,
Fanelli G, Bonadio AG, Montruccoli G and Bevilacqua G:
Bio-morphological events in the development of the human female
mammary gland from fetal age to puberty. Virchows Arch.
436:431–438. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reed JC, Miyashita T, Takayama S, Wang HG,
Sato T, Krajewski S, Aimé-Sempé C, Bodrug S, Kitada S and Hanada M:
BCL-2 family proteins: Regulators of cell death involved in the
pathogenesis of cancer and resistance to therapy. J Cell Biochem.
60:23–32. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Teraki Y and Shiohara T: Apoptosis and the
skin. Eur J Dermatol. 9:413–425. 1999.PubMed/NCBI
|
|
26
|
Tomaszewska R, Karcz D and Stachura J: An
immunohistochemical study of the expression of bcl-2 and p53
oncoproteins in pancreatic intraepithelial neoplasia and pancreatic
cancer. Int J Pancreatol. 26:163–171. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Won KY, Kim GY, Kim YW, Song JY and Lim
SJ: Clinicopathologic correlation of beclin-1 and bcl-2 expression
in human breast cancer. Hum Pathol. 41:107–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baspinar S, Bircan S, Orhan H, Kapucuoglu
N and Bozkurt KK: The relation of beclin 1 and bcl-2 expressions in
high grade prostatic intraepithelial neoplasia and prostate
adenocarcinoma: A tissue microarray study. Pathol Res Pract.
210:412–418. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang XH, Kleeman LK, Jiang HH, Gordon G,
Goldman JE, Berry G, Herman B and Levine B: Protection against
fatal sindbis virus encephalitis by beclin, a novel
Bcl-2-interacting protein. J Virol. 72:8586–8596. 1998.PubMed/NCBI
|
|
30
|
Decuypere JP, Parys JB and Bultynck G:
Regulation of the autophagic bcl-2/beclin 1 interaction. Cells.
1:284–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou F, Yang Y and Xing D: Bcl-2 and
Bcl-xL play important roles in the crosstalk between autophagy and
apoptosis. FEBS J. 278:403–413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cao SS, Su AP, Du XJ, Li A, Hu WM, Zhang
ZD, Tian BL, Lu HM, Ke NW and He ZP: The expressions and
correlation of bcl-2 and beclin-1 in pancreatic cancer. Sichuan Da
Xue Xue Bao Yi Xue Ban. 43:156–160. 2012.(In Chinese). PubMed/NCBI
|
|
33
|
Chun YS, Pawlik TM and Vauthey JN: 8th
Edition of the AJCC cancer staging manual: Pancreas and
hepatobiliary cancers. Ann Surg Oncol. 2017.(Epub ahead of
print).
|
|
34
|
Song S, Wang B, Zhang X, Hao L, Hu X, Li Z
and Sun S: Long-term diabetes mellitus is associated with an
increased risk of pancreatic cancer: A meta-analysis. PloS one.
10:e01343212015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Asiyanbola B, Gleisner A, Herman JM, Choti
MA, Wolfgang CL, Swartz M, Edil BH, Schulick RD, Cameron JL and
Pawlik TM: Determining pattern of recurrence following
pancreaticoduodenectomy and adjuvant 5-flurouracil-based
chemoradiation therapy: Effect of number of metastatic lymph nodes
and lymph node ratio. J Gastrointest Surg. 13:752–759. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim HS, Lee SH, Do SI, Lim SJ, Park YK and
Kim YW: Clinicopathologic correlation of beclin-1 expression in
pancreatic ductal adenocarcinoma. Pathol Res Pract. 207:247–252.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
McDonnell TJ and Korsmeyer SJ: Progression
from lymphoid hyperplasia to high-grade malignant lymphoma in mice
transgenic for the t (14; 18). Nature. 349:254–256. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
McDonnell TJ, Troncoso P, Brisbay SM,
Logothetis C, Chung LW, Hsieh JT, Tu SM and Campbell ML: Expression
of the protooncogene bcl-2 in the prostate and its association with
emergence of androgen-independent prostate cancer. Cancer Res.
52:6940–6944. 1992.PubMed/NCBI
|
|
39
|
Pietenpol JA, Papadopoulos N, Markowitz S,
Willson JK, Kinzler KW and Vogelstein B: Paradoxical inhibition of
solid tumor cell growth by bcl2. Cancer Res. 54:3714–3717.
1994.PubMed/NCBI
|
|
40
|
Callagy GM, Webber MJ, Pharoah PD and
Caldas C: Meta-analysis confirms BCL2 is an independent prognostic
marker in breast cancer. BMC Cancer. 8:1532008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Campani D, Esposito I, Boggi U, Cecchetti
D, Menicagli M, De Negri F, Colizzi L, Del Chiaro M, Mosca F,
Fornaciari G and Bevilacqua G: Bcl-2 expression in pancreas
development and pancreatic cancer progression. J Pathol.
194:444–450. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Casneuf VF, Fonteyne P, Van Damme N,
Demetter P, Pauwels P, de Hemptinne B, De Vos M, Van de Wiele C and
Peeters M: Expression of SGLT1, Bcl-2 and p53 in primary pancreatic
cancer related to survival. Cancer Invest. 26:852–859. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Knowlton K, Mancini M, Creason S, Morales
C, Hockenbery D and Anderson BO: Bcl-2 slows in vitro breast cancer
growth despite its antiapoptotic effect. J Surg Res. 76:22–26.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zinkel S, Gross A and Yang E: BCL2 family
in DNA damage and cell cycle control. Cell Death Differ.
13:1351–1359. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ke H, Parron VI, Reece J, Zhang JY,
Akiyama SK and French JE: BCL2 inhibits cell adhesion, spreading,
and motility by enhancing actin polymerization. Cell Res.
20:458–469. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang D, Chen MB, Wang LQ, Yang L, Liu CY
and Lu PH: Bcl-2 expression predicts sensitivity to chemotherapy in
breast cancer: A systematic review and meta-analysis. J Exp Clin
Cancer Res. 32:1052013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jiang LC, Huang SY, Zhang DS, Zhang SH, Li
WG, Zheng PH and Chen ZW: Expression of beclin 1 in primary
salivary adenoid cystic carcinoma and its relation to Bcl-2 and p53
and prognosis. Braz J Med Biol Res. 47:252–258. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pattingre S, Tassa A, Qu X, Garuti R,
Liang XH, Mizushima N, Packer M, Schneider MD and Levine B: Bcl-2
antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell.
122:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Klöppel G, Hruban R, Klimstra D, et al:
Solid-pseudopapillary Tumor of Pancreas. Bosman FT, Carneiro F,
Hruban RH and Theise ND: 327–333. 2010.
|
|
50
|
Potrc S, Kavalar R, Horvat M and Gadzijev
EM: Urgent Whipple resection for solid pseudopapillary tumor of the
pancreas. J Hepatobiliary Pancreat Surg. 10:386–389. 2003.
View Article : Google Scholar : PubMed/NCBI
|
